Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00702247
What this trial is testing

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera San Giovanni Battista
Large-scale testing (Phase 3)UnknownNCT00003603
What this trial is testing

Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Riverside Haematology Group 660
Large-scale testing (Phase 3)Study completedNCT00083551
What this trial is testing

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

Who this might be right for
Multiple Myeloma
University of Arkansas 668
Not applicableStudy completedNCT00789256
What this trial is testing

Low Dose Melphalan and Bortezomib for AML and High-Risk MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndromes
Dartmouth-Hitchcock Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT00004088
What this trial is testing

Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
City of Hope Medical Center 77
Not applicableUnknownNCT03687463
What this trial is testing

Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 6
Not applicableStudy completedNCT03609827
What this trial is testing

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

Who this might be right for
Hematologic MalignanciesNonmalignant DiseasesImmunodeficiencies+5 more
University of California, San Francisco 25
Testing effectiveness (Phase 2)Ended earlyNCT01617213
What this trial is testing

Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Virginia 1
Early research (Phase 1)Study completedNCT00005835
What this trial is testing

N99-02: Melphalan and Buthionine Sulfoximine

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 31
Testing effectiveness (Phase 2)Looking for participantsNCT06378060
What this trial is testing

Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Hematology department of the 920th hospital 30
Testing effectiveness (Phase 2)Study completedNCT00691704
What this trial is testing

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy

Who this might be right for
Multiple Myeloma
Cristina Gasparetto 18
Early research (Phase 1)Study completedNCT00001576
What this trial is testing

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Who this might be right for
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)UnknownNCT04380376
What this trial is testing

Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia

Who this might be right for
COVID-19Viral Pneumonia
Federal State Budgetary Institution, Pulmonology Scientific Research Institute 60
Early research (Phase 1)Study completedNCT00002730
What this trial is testing

Chemotherapy in Treating Children With Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Large-scale testing (Phase 3)Study completedNCT01208766
What this trial is testing

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 1,503
Not applicableLooking for participantsNCT07364474
What this trial is testing

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Who this might be right for
Uveal Melanoma
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT05504291
What this trial is testing

Give Treatment Inside the Eye to Treat Retinoblastoma

Who this might be right for
Bilateral RetinoblastomaChildhood Intraocular RetinoblastomaGroup D Retinoblastoma+2 more
Children's Oncology Group 26
Early research (Phase 1)WithdrawnNCT00661336
What this trial is testing

A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Duke University
Large-scale testing (Phase 3)Study completedNCT00602511
What this trial is testing

Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 300
Testing effectiveness (Phase 2)Ended earlyNCT04412707
What this trial is testing

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients

Who this might be right for
RRMM
Oncopeptides AB 27
Next Page